LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

Home・Aandelen Lijst・Vivani Medical

Vivani Medical

Gesloten

1.13 1.8

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1.08

Max

1.18

Belangrijke statistieken
By Trading Economics
Inkomsten	614K -6.5M
Werknemers	37

Dividenden
By Dow Jones
Volgende Winsten	30 mrt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-24M 80M
Vorige openingsprijs	-0.67
Vorige sluitingsprijs	1.13

Vivani Medical Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

20 mrt 2026, 17:19 UTC

Belangrijke Nieuwsgebeurtenissen

Chubb to Assume Risk, Issue Policies for $20 Billion Strait of Hormuz Insurance Facility

20 mrt 2026, 16:56 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: PMI Data to Show Middle East War's Impact on Sentiment

20 mrt 2026, 16:56 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: PMI Data to Show Middle -2-

20 mrt 2026, 16:45 UTC

Belangrijke Nieuwsgebeurtenissen

The Week in Oil: U.S. Seeks to Ease Concerns Over War But Supply Risks Mount

20 mrt 2026, 16:22 UTC

Belangrijke Nieuwsgebeurtenissen

NYMEX Overview: Petroleum Futures Rise, Leaving Most Contracts on Track for Solid Weekly Gains -- OPIS

20 mrt 2026, 20:50 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Basic Materials Roundup: Market Talk

20 mrt 2026, 20:50 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Health Care Roundup: Market Talk

20 mrt 2026, 19:55 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Brent Crude Closes Out Volatile Week Higher -- Market Talk

20 mrt 2026, 19:28 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Natural Gas Falls as Traders Sell Ahead of the Weekend -- Market Talk

20 mrt 2026, 19:28 UTC

Acquisities, Fusies, Overnames

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

20 mrt 2026, 18:39 UTC

Marktinformatie

Gold Settles With Largest Weekly Dollar Decline on Record -- Market Talk

20 mrt 2026, 18:31 UTC

Acquisities, Fusies, Overnames

Honeywell Announces Pricing of Debt Tender Offers >HON

20 mrt 2026, 18:19 UTC

Acquisities, Fusies, Overnames

Why Mayo and Soap No Longer Mix for Unilever -- Update

20 mrt 2026, 18:15 UTC

Marktinformatie

iMarkets May Be Wrong in Pricing for Canadian Rate Increases -- Market Talk

20 mrt 2026, 17:57 UTC

Marktinformatie

U.S. Oil Rig Count Inches Up -- Market Talk

20 mrt 2026, 17:04 UTC

Belangrijke Nieuwsgebeurtenissen

Chubb to Assume Risk, Issue Policies for $20B Strait of Hormuz Insurance Facility

20 mrt 2026, 16:20 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Basic Materials Roundup: Market Talk

20 mrt 2026, 16:20 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Health Care Roundup: Market Talk

20 mrt 2026, 15:40 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Unilever, McCormick Deal Makes Strategic Sense, But Risk Remains -- Market Talk

20 mrt 2026, 15:30 UTC

Winsten

Gemini Space Station's Earnings 'Better Than Feared.' Can They Save the Stock? -- Barrons.com

20 mrt 2026, 15:26 UTC

Marktinformatie

Winsten

Belangrijke Nieuwsgebeurtenissen

Lands' End: War Impacts Weighing on Some European Consumers -- Market Talk

20 mrt 2026, 15:26 UTC

Acquisities, Fusies, Overnames

Why Mayo and Soap No Longer Mix for Unilever -- WSJ

20 mrt 2026, 15:25 UTC

Marktinformatie

Gilt Selloff Shows Vulnerability of U.K.'s Economy -- Market Talk

20 mrt 2026, 15:19 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

UBS Raises Oil Price Forecast as Middle East Conflict Escalates -- Market Talk

20 mrt 2026, 14:58 UTC

Belangrijke Nieuwsgebeurtenissen

Chevron Jumps Into Top 20 Most Valuable U.S. Companies. The Iran War's Other Big Stock Movers. -- Barrons.com

20 mrt 2026, 14:55 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Gold Lower as Speculative Pullback Extends -- Market Talk

20 mrt 2026, 14:54 UTC

Acquisities, Fusies, Overnames

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

20 mrt 2026, 14:53 UTC

Acquisities, Fusies, Overnames

Unilever, McCormick Deal Would Create a New Condiment King -- WSJ

20 mrt 2026, 14:46 UTC

Marktinformatie

U.K. Government Bonds Selloff More Pronounced Than Peers -- Market Talk

20 mrt 2026, 14:45 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Price Forecasts For 2026-27 Raised at UBS -- Market Talk

Peer Vergelijking

Prijswijziging

Vivani Medical Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

Buy

Hold

Sell

Gebaseerd op 0 analisten die aandelenratings hebben gegeven aan Vivani Medical - Dist in de afgelopen 3 maanden.

Financieel

Verkoop- en administratiekosten

Winst voor belastingen

Verkoop

Operationele winst

Over Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.